Second comprehensive volume focuses on anti-inflammatory nutraceuticals and their role in prevention and therapy of various chronic diseases. Food and drug administration (FDA) approved drugs such as steroids, non-steroidal anti-inflammatory drugs (NSAIDS), statins and metformin have been shown to modulate inflammatory pathways, but their long-term intake has been associated with numerous side effects. Thus dietary agents which can modulate inflammatory pathways in humans, are likely to exhibit enormous potential. Leading experts describe the latest results of anti-inflammatory nutraceuticals and their role in prevention and therapy of various chronic diseases.
Cinnamon and Chronic Diseases.- Silymarin and its Role in Chronic Diseases.- Eugenol and its Role in Chronic Diseases.- Catechins and its Role in Chronic Disease.- Capsaicin and its Role in Chronic Diseases.- Diallyl Sulfide and its Role in Chronic Diseases.- Lupeol and its Role in Chronic Diseases.- Gingerol and its Role in Chronic Diseases.- Potential Use of Flavopiridol in Treatment of Chronic Diseases.- Plumbagin and its Role in Chronic Diseases.
Dr. Subash Gupta is currently an Assistant professor at Department of Biochemistry, Institute of Science, Banaras Hindu University, India.
Dr. Sahdeo Prasad is currently at the Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, USA.
Dr. Bharat Aggarwal is currently a Founding Director, Inflammation Research Institute, San Diego, California, USA. He was a Ransom Horne, Jr. Distinguished Professor of Experimental Therapeutics, Cancer Medicine and Immunology, The University of Texas MD Anderson Cancer Center, USA.
